Clinical Trials on Inhalation in Belgium

Total 12 results

Laboratory of Movement, Condorcet, Tournai, Belgium

Completed

Effect of a Modified Oxygen Mask Associated to Nasal Prongs During a High Flow Oxygenation Method

Oxygen Inhalation Therapy

Belgium
Chiesi Farmaceutici S.p.A.

Completed

Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule for Oral Inhalation Via Aerolizer® Device

COPD

Belgium
Chiesi Farmaceutici S.p.A.
SGS S.A.

Recruiting

Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

Asthma

Belgium
Universitair Ziekenhuis Brussel

Recruiting

Handheld-multimedia Versus Oral Midazolam in Pediatric on Perioperative Anxiety

Tonsillectomy | Preanesthetic Medication | Circumcision | Ambulatory Surgery | Inhalation Anesthesia | Dental Care | Perioperative Anxiety

Belgium
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch Burns Foundation

Terminated

Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma (Hepburn)

Burn Injury | Inhalation Injury

Netherlands, Australia, Belgium
GlaxoSmithKline
University Hospital, Antwerp

Completed

Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients

Idiopathic Pulmonary Fibrosis

Belgium
GlaxoSmithKline

Completed

Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison

Pulmonary Disease, Chronic Obstructive

Belgium
GlaxoSmithKline

Completed

Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry

Pulmonary Disease, Chronic Obstructive

Belgium
Abbott Medical Devices

Completed

Lead Registry for Optim Leads (OPTIMUM)

Optim Lead Insulation Related Adverse Events

United States, Belgium, Germany
Novartis Pharmaceuticals
Erasmus Medical Center; Fundacion Clinic per a la Recerca Biomédica; University... and other collaborators

Completed

Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection (iBEST-1)

Non-cystic Fibrosis Bronchiectasis

Germany, Belgium, France, United Kingdom, Spain, Italy
GlaxoSmithKline

Completed

A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))

Pulmonary Disease, Chronic Obstructive

France, Germany, Spain, Russian Federation, Belgium, Ukraine, Philippines, Italy, Poland
Gilead Sciences
Covance; ClinPhone, Inc.; Chiltern International Inc.

Completed

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

Cystic Fibrosis

Belgium, France, Germany, Italy, Netherlands, Spain, United States, Ireland, United Kingdom, Portugal, Austria, Denmark, Switzerland

3

Subscribe